Medical device maker Medtronic plc (NYSE: MDT) reported a modest increase in revenues and adjusted profit for the second quarter of 2025.
MDT Earnings: Highlights of Medtronic’s Q2 2025 financial results
Categories
Health Care
Earnings Summary: Baxter International reports higher sales for Q3 2024
Medical device maker Baxter International Inc. (NYSE: BAX) announced financial results for the third quarter of 2024, reporting a modest increase in
Earnings Summary: Moderna swings to profit in Q3 on modest revenue growth
Biotechnology company Moderna, Inc. (NASDAQ: MRNA) Thursday reported net income for the third quarter of 2024, compared to a loss last year
CVS Earnings: CVS Health Q3 adj. profit drops despite 6% revenue growth
Healthcare conglomerate CVS Health Corporation (NYSE: CVS) on Wednesday announced third-quarter 2024 results, reporting a decrease in adjusted earnings and an increase
What to look for when CVS Health (CVS) reports Q3 earnings
Healthcare company CVS Health Corporation (NYSE: CVS) is all set to report earnings next week, with Wall Street expecting a mixed outcome.
Earnings Summary: Everything you need to know about Cardinal Health’s Q1 report
Cardinal Health (NYSE: CAH), a leading pharmaceuticals distributor, on Friday reported an increase in adjusted profit for the first quarter of 2025,
Infographic: How Merck (MRK) performed in Q3 2024
Merck (NYSE: MRK) reported its third quarter 2024 earnings results today. Sales grew 4% year-over-year to $16.7 billion. Excluding FX, sales growth
Key metrics from Bristol Myers Squibb’s (BMY) Q3 2024 earnings results
Bristol Myers Squibb (NYSE: BMY) reported its third quarter 2024 earnings results today. Total revenues increased 8% year-over-year to $11.9 billion. Revenues
Key highlights from Biogen’s (BIIB) Q3 2024 earnings results
Biogen Inc. (NASDAQ: BIIB) reported its third quarter 2024 earnings results today. Total revenue decreased 3% year-over-year to $2.46 billion. Revenues were
Eli Lilly (LLY) Q3 2024 Earnings: Key financials and quarterly highlights
Eli Lilly and Company (NYSE: LLY) reported its third quarter 2024 earnings results today. Worldwide revenue was $11.44 billion, up 20% compared
Key takeaways from Pfizer’s (PFE) Q3 2024 earnings report
Shares of Pfizer Inc. (NYSE: PFE) were down over 1% on Tuesday, despite the company delivering better-than-expected earnings results for the third
PFE Earnings: Key quarterly highlights from Pfizer’s Q3 2024 financial results
Pfizer Inc. (NYSE: PFE) reported its third quarter 2024 earnings results today. Revenues increased 31% year-over-year to $17.7 billion. Revenues increased 32%
Earnings Summary: HCA Healthcare reports Q3 2024 financial results
Hospital operator HCA Healthcare, Inc. (NYSE: HCA) on Friday announced financial and operating results for the third quarter ended September 30, 2024.
Earnings Summary: Everything you need to know about Centene’s Q3 report
Healthcare service provider Centene Corporation (NYSE: CNC) announced third-quarter 2024 results, reporting higher revenue and a decline in adjusted profit. Total revenues
Earnings Summary: Thermo Fisher Scientific (TMO) reports Q3 2024 results
Thermo Fisher Scientific Inc. (NYSE: TMO) on Wednesday reported financial results for the third quarter of 2024. The company also issued full-year
Intuitive Surgical (ISRG) reports double-digit growth in Q3 revenue and earnings
Medical device company Intuitive Surgical, Inc. (NASDAQ: ISRG) has reported a sharp increase in earnings for the third quarter of 2024, reflecting
Abbott Laboratories (ABT) Q3 2024 Earnings: Key financials and quarterly highlights
Abbott Laboratories (NYSE: ABT) reported third quarter 2024 earnings results today. Total reported sales increased 4.9% year-over-year to $10.6 billion. Organic sales
Key metrics from UnitedHealth Group’s (UNH) Q3 2024 earnings results
UnitedHealth Group (NYSE: UNH) reported its third quarter 2024 earnings results today. Total revenues increased 9% year-over-year to $100.8 billion. Net earnings
Johnson & Johnson (JNJ) Q3 2024 Earnings: Key financials and quarterly highlights
Johnson & Johnson (NYSE: JNJ) reported its third quarter 2024 earnings results today. Reported sales increased 5.2% year-over-year to $22.5 billion. GAAP earnings
Earnings Preview: Johnson & Johnson bets on innovation to stay in growth mode
Over the years, Johnson & Johnson (NYSE: JNJ) has remained a dominant player in the medical industry, benefitting from its unique business
Walgreens Boots Alliance’s Q4 results likely to reflect market challenges
Walgreens Boots Alliance, Inc. (NASDAQ: WBA) has been struggling to maintain sales momentum and profitability for quite some time due to a